FTV · Fortive Corp

$60.25 +0.75 (+1.26%) At close · Aug 26

Market Cap

$18.14B

304.86M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$4.16B +1.9%

FY2025

Net Income

$579.2M -30.5%

FY2025

Gross Margin

63.5% -0.7pp

FY2025

Operating Margin

17.32% -0.2pp

FY2025

Diluted EPS

$1.73 -26.7%

FY2025

Operating Cash Flow

$1.08B -29.1%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014
Revenue	-10.6%	-2.1%	-3.9%	$4.35B	$4.24B	$4.16B^G	$4.08B	$3.91B	$5.83B	$5.25B	$4.63B	$4.56B	$6.45B	$5.76B	$5.38B	$6.18B	$6.34B
Cost of Revenue	-14.9%	-5.6%	-7.1%	—	$1.56B	$1.52B	$1.46B	$1.44B	$2.46B	$2.25B	$2.03B	$2.08B	$1.61B	$2.83B	$2.69B	$3.18B	$3.29B
Gross Profit	-7.7%	+0.2%	-1.3%	—	$2.68B	$2.64B	$2.62B	$2.48B	$3.36B	$3.01B	$2.61B	$2.48B	$2.19B	$2.92B	$2.69B	$3B	$3.05B
Gross Margin	—	—	—	—	—	63.5%	64.18%	63.29%	57.73%	57.23%	56.29%	54.41%	33.88%	50.75%	49.93%	48.55%	48.12%
Research & Development	-13.6%	-4.2%	-3.7%	—	$261.7M	$259.2M	$251.3M	$237M	$401.5M	$354.8M	$320.7M	$320.3M	$278.1M	$369.3M	$351M	$377.7M	$387.6M
Selling, General & Administrative	-5.3%	-1.0%	+2.1%	—	$1.67B	$1.66B	$1.65B	$1.67B	$1.96B	$1.84B	$1.75B	$1.72B	$1.26B	$1.41B	$1.27B	$1.35B	$1.42B
Amortization of Intangibles	-1.2%	+3.5%	+15.3%	—	—	$368M	$369M	$367M	$382M	$321M	$310M	$261M	$105M	$65M	$85M	$89M	$90M
Depreciation & Amortization	-2.0%	+2.6%	+9.5%	—	$443.2M	$437.6M	$430.9M	$426.2M	$465.6M	$395.5M	$384M	$341.5M	$174.2M	$158.3M	$160.9M	$176.9M	$178M
Restructuring Charges	-20.6%	—	—	—	—	—	—	—	—	—	—	—	$6M	$16M	$15M	$12M	—
Total Operating Expenses	—	—	—	—	-$1.93B	-$1.92B	-$1.9B	-$1.9B	-$2.36B	—	—	—	—	—	—	—	—
Operating Income	-10.0%	+6.0%	-5.5%	—	$746.6M	$720.2M	$716.3M	$574M	$987.4M	$812.8M	$539.4M	$443.9M	$645.3M	$1.14B	$1.06B	$1.27B	$1.25B
Operating Margin	—	—	—	—	—	17.32%	17.55%	14.67%	16.95%	15.47%	11.64%	9.73%	10%	19.86%	19.74%	20.55%	19.65%
EBITDA	-7.3%	+4.6%	-2.2%	—	$1.19B	$1.16B	$1.15B	$1B	$1.45B	$1.21B	$923.4M	$785.4M	$819.5M	$1.3B	$1.22B	$1.45B	$1.42B
Interest Expense	—	—	—	—	-$120.1M	-$120.5M	-$152.8M	-$123.5M	-$98.3M	$103.2M	$148.5M	$142.6M	$77.2M	$88.7M	$46.4M	$0	$0
Other Non-Operating Income	—	—	—	—	$5.6M	$2.5M	-$57.2M	-$17.4M	-$15.6M	-$14.1M	-$2.4M	-$5.4M	-$2.3M	$4M	-$4.8M	—	—
Gain on Sales of Real Estate	—	—	—	—	—	—	—	—	$0	$0	$5.3M	$0	$0	$8M	$0	$0	—
Equity in Earnings of Unconsolidated Entities	—	—	—	—	—	$0	-$39.4M	-$17.3M	-$17.3M	—	—	—	—	—	—	—	—
Pretax Income	-11.7%	-16.8%	-7.2%	—	$632.1M	$602.2M	$506.3M	$433.1M	$873.5M	$677.5M	$1.51B	$336.7M	$565.8M	$1.07B	$1.01B	$1.27B	$1.28B
Income Tax	-16.2%	+4.6%	-16.2%	—	$75.6M	$69.5M	$23.8M	$24.7M	$118.3M	$63.3M	$55.5M	$68.6M	$75.6M	$189.3M	$270.3M	$405.9M	$395.8M
Net Income	-8.5%	-18.5%	-3.9%	—	$543.7M	$579.2M	$832.9M	$865.8M	$755.2M	$608.4M	$1.61B	$738.9M	$2.91B	$1.04B	$872.3M	$863.8M	$883.4M
Net Margin	—	—	—	—	—	13.93%	20.41%	22.12%	12.96%	11.58%	34.81%	16.19%	45.16%	18.15%	16.22%	13.98%	13.94%
Net Income Available to Common Stockholders	-17.5%	-21.4%	—	—	—	—	—	$865.8M	$755.2M	$573.9M	$1.54B	$669.9M	$2.88B	$1.04B	$872.3M	—	—
Comprehensive Income	—	—	—	—	$648.1M	$753.3M	$693.6M	$865.4M	—	—	—	—	—	—	—	—	—
EPS (Basic) USD/shares	+2.9%	-12.8%	+1.0%	—	—	$1.74	$2.39	$2.46	$1.60	$1.24	$3.45	$1.50	$6.28	$1.90	$1.59	$1.58	$1.61
EPS (Diluted) USD/shares	+3.0%	-12.6%	+0.9%	$2.95 – $3.05*	—	$1.73^G	$2.36^G	$2.43^G	$1.58^G	$1.23	$3.38	$1.48	$6.19	$1.87	$1.58	$1.58	$1.61
Shares Outstanding (Basic Avg) shares	-11.1%	-5.8%	-4.9%	—	—	332M	349.2M	352.5M	472.94M	463.12M	447.73M	445.61M	458.48M	551.05M	548.2M	547.41M	547.41M
Shares Outstanding (Diluted Avg) shares	-11.3%	-6.8%	-4.8%	—	—	334.6M	352.8M	355.6M	478.78M	467.5M	476.39M	451.18M	465.38M	559.14M	550.74M	547.41M	547.41M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2014–FY2025: $3.22B in buybacks, $933M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

5.02×

Peer median 4.86×

EV/EBIT

28.49×

Peer median 27.42×

P/E (TTM)

35.63×

Peer median 37.73×

Peer medians compare against the 13 similar-size Scientific & Technical Instruments companies (of 40 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Intelligent Operating Solutions	$2,856,300,000	$2,793,200,000	$2,684,500,000	$2,466,100,000	$2,169,400,000	$1,883,700,000	$1,898,900,000	$1,576,300,000
Advanced Healthcare Solutions	$1,302,800,000	$1,287,700,000	$1,229,400,000	$1,207,300,000	$1,236,400,000	$1,099,400,000	$856,600,000	$322,700,000
Precision Technologies	—	—	—	$2,152,300,000	$1,848,900,000	$1,651,300,000	$1,808,400,000	$1,901,400,000

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
North America	$2,491,100,000	$2,416,800,000	$2,292,400,000	—	—	—	—	—
Asia Pacific	$730,100,000	$733,300,000	$727,200,000	—	—	—	—	—
EMEA	$725,800,000	$721,100,000	$697,600,000	—	—	—	—	—
Latin America	$212,100,000	$209,700,000	$196,700,000	—	—	—	—	—
China	—	—	—	$702,100,000	$650,700,000	$534,100,000	$501,200,000	$476,800,000
United States	—	—	—	$3,136,800,000	$2,683,000,000	$2,436,600,000	$2,394,200,000	$1,875,800,000
Countries Excluding United States and China	—	—	—	$1,986,800,000	$1,921,000,000	$1,663,700,000	$1,668,500,000	$1,447,800,000

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Product	$3,341,300,000	$3,290,900,000	$3,157,700,000	$4,920,100,000	$4,496,100,000	$3,956,700,000	$3,922,500,000	$3,360,500,000
Service	$817,800,000	$790,000,000	$756,200,000	$905,600,000	$758,600,000	$677,700,000	$641,400,000	$439,900,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Intelligent Operating Solutions	$738,300,000	$708,000,000	$629,900,000	$519,400,000	$408,500,000	$317,800,000	$289,000,000	$350,300,000
Advanced Healthcare Solutions	$138,600,000	$138,500,000	$83,800,000	$95,600,000	$101,900,000	$2,100,000	-$72,000,000	$5,300,000
Industrial Technologies	—	—	—	—	—	—	$553,900,000	$525,600,000
Precision Technologies	—	$500,000,000	$544,200,000	$503,600,000	$408,000,000	$321,700,000	$324,600,000	$381,500,000
Professional Instrumentation	—	—	—	—	—	—	$547,900,000	$744,600,000

Operating Margin by Segment (%)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Intelligent Operating Solutions	25.8%	25.3%	23.5%	21.1%	18.8%	16.9%	15.2%	22.2%
Advanced Healthcare Solutions	10.6%	10.8%	6.8%	7.9%	8.2%	0.2%	-8.4%	1.6%
Precision Technologies	—	—	—	23.4%	22.1%	19.5%	17.9%	20.1%

Key facts CIK 1659166 CUSIP 34959J108 13F (30d) 601 filings 586 filers Visit website Investor relations